Carreras
Chris Carreras, Erie, CO US
Patent application number | Description | Published |
---|---|---|
20140360394 | PRINTING PROCESS USING SOFT PHOTOPOLYMER PLATES - The present invention relates to using soft photopolymer plates in a printing process, and more specifically, to an apparatus and methods of using soft photopolymer materials to decorate an exterior surface of cylindrical metallic containers with high definition graphics and other indicia. | 12-11-2014 |
20150217559 | VARIABLE PRINTING PROCESS USING SOFT SECONDARY PLATES AND SPECIALTY INKS - The present invention relates to using soft secondary plates and specialty inks in a printing process. More specifically, the present invention relates to an apparatus and methods of using soft secondary plates made of a rubber comprising a saturated chain of polymethylene or a photopolymer material to decorate an exterior surface of cylindrical metallic containers with high definition graphics and other indicia. | 08-06-2015 |
Christopher Carreras, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20130274285 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS - The present disclosure is directed to compounds and methods for treating irritable bowel syndrome, chronic kidney disease and end stage renal disease by administering to a subject in need thereof a compound or a pharmaceutically acceptable salt thereof, wherein the compound has the structure | 10-17-2013 |
20140107074 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS - The present disclosure is directed to compounds of the structure (X): | 04-17-2014 |
20150190389 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDER - The present disclosure is directed to compounds of the structure (X): | 07-09-2015 |
20150299131 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS - The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist-induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders. | 10-22-2015 |
20150336892 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS - The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist-induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders. | 11-26-2015 |
Christopher Carreras, Belmont, CA US
Patent application number | Description | Published |
---|---|---|
20120263670 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS - The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist-induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders. | 10-18-2012 |
20130336918 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT - Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): | 12-19-2013 |
20130336919 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT - Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): | 12-19-2013 |
20130336920 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT - Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): | 12-19-2013 |
20130336921 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT - Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): | 12-19-2013 |
20140023611 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT - Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed. | 01-23-2014 |
20150148311 | NON-SYSTEMIC TGR5 AGONISTS - Compounds having the following structure (I): | 05-28-2015 |
20150157637 | COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT - Compounds having activity as phosphate transport inhibitors, more specifically, inhibitors of intestinal apical membrane Na/phosphate co-transport, are disclosed. The compounds have the following structure (I): | 06-11-2015 |
Enric Santanach Carreras, Marseille FR
Patent application number | Description | Published |
---|---|---|
20150030648 | Dispersion intended for encapsulating an active product and associated use - A dispersion including a plurality of bodies dispersed in a continuous phase. Each dispersed body including an internal drop formed with an internal phase miscible with the continuous phase, the internal drop ( | 01-29-2015 |
20150044263 | Kit comprising two separate compositions, notably for cosmetic application - A kit comprising two separate compositions (A) and (B). Composition (A) is an aqueous gel with a viscosity of less than 11 Pa·s and contains at least one capsule including: a liquid core with at least one active ingredient and a gelled envelope totally encapsulating the liquid core. The gelled envelope includes at least one polyelectrolyte in the gelled state. Composition (B) includes a depolymerizing agent. | 02-12-2015 |
Giuseppe Carreras, Napoli (na) IT
Patent application number | Description | Published |
---|---|---|
20110180662 | LANDING GEAR - A bogie-type landing gear for aircraft is provided. The landing gear includes at least one front wheel and at least one rear wheel connected to a beam, a rocking arm centrally and rotatably connected to said beam, and a shock absorbing element. The rocking arm ends and the shock absorbing element, which are distal to the wheels, are articulated on a lever element hinged on the aircraft frame, onto which an actuator assembly for rotating said lever element urges between a position in which the wheels are in an operative configuration and a position in which the wheels are retracted in the landing gear bay. | 07-28-2011 |
Iacopo Carreras, Sopramonte IT
Patent application number | Description | Published |
---|---|---|
20100222080 | CONTEXT AWARE WIRELESS INFORMATION SYSTEM AND METHOD - The invention relates to a system and method for providing context-aware services in pervasive computing environments. Specifically it targets environments where a plurality of intermittently connected portable computing devices interact with each other and possibly a plurality of embedded computing devices, that can be fixed in a certain environment. Said portable computing devices communicate with each other via some forms of proximity wireless communications when getting within mutual communication range. Said embedded devices can communicate with said portable devices via a wireless communication interface when getting within mutual communication range. The method proposed is particularly suited for transparent dissemination (i.e., requiring no explicit user intervention) of contextual information, in the form of data which relates to the context the user is in. Some examples of specific forms of contextual information include, but are not limited to: location information, time information, user activity information, information on locally available resources. | 09-02-2010 |
Manuel Roig Carreras, Murcia ES
Patent application number | Description | Published |
---|---|---|
20120022471 | Cosmetic Composition for th Ecare and Correction of Telangiectasias - The present invention relates to a dermocosmetic composition of localised topical application in cream and/or emulsion form, to the procedure for obtainment thereof together with use thereof for care and correction of telangiectasias and to the method of administration thereof. | 01-26-2012 |
Nuria Carreras, Caldes De Montbui (barcelona) ES
Patent application number | Description | Published |
---|---|---|
20090306128 | PHARMACEUTICAL COMPOSITIONS CONTAINING A FLUOROQUINOLONE ANTIBIOTIC DRUG - Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions. | 12-10-2009 |
20130137715 | Pharmaceutical Compositions Containing A Fluoroquinolone Antibiotic Drug - Pharmaceutical compositions containing a fluoroquinolone antibiotic drug are disclosed. The compositions exhibit improved homogeneity, improved bioavailability, lower turbidity or a combination thereof. The composition can be use as otic or nasal compositions, but are particularly useful as ophthalmic compositions. | 05-30-2013 |
Nuria Carreras, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090286826 | PHARMACEUTICAL COMPOSITIONS HAVING CARBOXYVINYL POLYMER AND POVIDONE POLYMER - The present invention is directed to pharmaceutical compositions, such as ophthalmic gels. The compositions typically include a carboxyvinyl polymer. A povidone polymer is also typically included to stabilize the carboxyvinyl polymer against agents or ingredients (e.g., therapeutic agent) that can otherwise cause instability to the carboxyvinyl polymer. | 11-19-2009 |
20120029073 | PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY - The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil. | 02-02-2012 |
Rafael A. Carreras US
Patent application number | Description | Published |
---|---|---|
20120152864 | Self-disposal of solids in an immiscible liquid separator - A separator for separating oils from waste water and solids. Waste liquids are drained into a baffle tube of the separator so that the oils rise and the waste water and solids migrate to the bottom of the separator. A collection head having a restriction is located at the bottom of the separator and is adapted for suctioning the waste water and the solids therein and carrying the same to a discharge outlet of the separator. Waste liquids drained into the separator provide the hydraulic force to accelerate the waste water and solids into the collection head. Liquids drained into the separator also provide the hydraulic force that allows the oils to be drained from the top of the separator. | 06-21-2012 |
Richard A. Carreras, Albuquerque, NM US
Patent application number | Description | Published |
---|---|---|
20160034618 | SYSTEM AND MODEL FOR REAL-TIME PREDICTIVE LASER BEAM PROPAGATION - The present invention is a method for real-time predictive laser beam propagation through various atmospheric conditions and over predetermined distances. The invention includes loading input parameters into an embedded control scheme of a laser system. A prediction of one or more laser beam parameters is generated and a computational error is quantified for the generated laser beam parameters. One or more parameters for the laser system are then chosen based on the prediction and based on the quantified computational error. The chosen parameters are within a predetermined tolerance. A laser system is then built or adjusted using the one or more chosen parameters. | 02-04-2016 |